Marinus Pharmaceuticals, Inc. (MRNS)
Market Cap | 65.37M |
Revenue (ttm) | 28.29M |
Net Income (ttm) | -145.34M |
Shares Out | 54.93M |
EPS (ttm) | -2.64 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 814,406 |
Open | 1.260 |
Previous Close | 1.280 |
Day's Range | 1.150 - 1.300 |
52-Week Range | 1.100 - 11.260 |
Beta | 1.11 |
Analysts | Buy |
Price Target | 10.86 (+812.61%) |
Earnings Date | Aug 8, 2024 |
About MRNS
Marinus Pharmaceuticals, Inc., a pharmaceutical company, focuses on development and commercialization of therapeutic products for patients suffering from rare genetic epilepsies and other seizure disorders. It offers ZTALMY (ganaxolone), an oral suspension for the treatment of seizures associated with cyclin-dependent kinase-like 5 deficiency disorder for adult and pediatric patient populations in acute and chronic care, and in-patient and self-administered settings. The company's ZTALMY product candidate acts at synaptic and extrasynaptic GABA... [Read more]
Financial Performance
In 2023, MRNS's revenue was $30.99 million, an increase of 21.63% compared to the previous year's $25.48 million. Losses were -$141.41 million, 613.6% more than in 2022.
Financial StatementsAnalyst Forecast
According to 7 analysts, the average rating for MRNS stock is "Buy." The 12-month stock price forecast is $10.86, which is an increase of 812.61% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/n/s/press1-2507823.jpg)
August 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNS
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/m/w/press4-2507826.jpg)
August 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against MRNS
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/i/b/press2-2507767.jpg)
MRNS LAWSUIT ALERT: Levi & Korsinsky Notifies Marinus Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/2/k/press12-2507755.jpg)
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Marinus Pharmaceuticals, Inc. (MRNS)
Shareholders with losses of $100,000 or more are encouraged to contact the firm Shareholders with losses of $100,000 or more are encouraged to contact the firm
![](https://cdn.snapi.dev/images/v1/a/6/press18-2507601.jpg)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/c/j/press1-2507561.jpg)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit – MRNS
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/h/y/press13-2507518.jpg)
The Schall Law Firm Initiates A Probe Into Marinus Pharmaceuticals Inc And Motivates Affected Investors To Connect
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut...
![](https://cdn.snapi.dev/images/v1/3/d/press10-2507078.jpg)
Shareholders that lost money on Marinus Pharmaceuticals, Inc.(MRNS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/3/6/press6-2507049.jpg)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
NEW YORK, July 02, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS) of a class action securities lawsuit.
![](https://cdn.snapi.dev/images/v1/u/7/press17-2507035.jpg)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit - MRNS
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/3/u/press11-2507008.jpg)
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu...
![](https://cdn.snapi.dev/images/v1/m/1/press7-2506789.jpg)
Shareholders Who Lost Money on Marinus Pharmaceuticals, Inc. (MRNS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/y/q/press20-2506800.jpg)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit - MRNS
NEW YORK, NY / ACCESSWIRE / July 2, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/g/v/press12-2506681.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Marinus Pharmaceuticals, Inc. - MRNS
NEW YORK , July 2, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Marinus Pharmaceuticals, Inc. ("Marinus" or the "Company") (NASDAQ: MRNS). Such inves...
![](https://cdn.snapi.dev/images/v1/z/w/press11-2505788.jpg)
Levi & Korsinsky Notifies Shareholders of Marinus Pharmaceuticals, Inc. (MRNS) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/z/i/press5-2505782.jpg)
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Marinus Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – MRNS
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) between March 17, 2...
![](https://cdn.snapi.dev/images/v1/g/x/press10-2505233.jpg)
The Gross Law Firm Notifies Shareholders of Marinus Pharmaceuticals, Inc.(MRNS) of a Class Action Lawsuit and an Upcoming Deadline
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS).
![](https://cdn.snapi.dev/images/v1/m/u/press7-2505212.jpg)
Marinus Pharmaceuticals, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights - MRNS
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/k/w/press15-2505219.jpg)
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Marinus Pharmaceuticals, Inc.(MRNS) Shareholders
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/w/g/press18-2505175.jpg)
MRNS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Marinus Pharmaceuticals, Inc. Investors to Join the Class Action Lawsuit!
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Marinus Pharmaceu...
![](https://cdn.snapi.dev/images/v1/j/l/press8-2505072.jpg)
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of August 5, 2024 in Marinus Pharmaceuticals, Inc. Lawsuit - MRNS
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/0/m/press12-2505075.jpg)
Shareholders that Lost Money on Marinus Pharmaceuticals, Inc.(MRNS) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...
![](https://cdn.snapi.dev/images/v1/c/o/press1-2505021.jpg)
The Schall Law Firm Embarks On An Examination Of Allegations Against Marinus Pharmaceuticals Inc And Calls On Impacted Investors To Contact
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut...
![](https://cdn.snapi.dev/images/v1/4/h/press16-2505015.jpg)
The Schall Law Firm Launches Investigation Into Against Marinus Pharmaceuticals Inc And Encourages Impacted Investors To Get In Touch
LOS ANGELES, CA / ACCESSWIRE / July 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Marinus Pharmaceut...
![](https://cdn.snapi.dev/images/v1/e/i/press14-2504436.jpg)
Investors in Marinus Pharmaceuticals, Inc. Should Contact Levi & Korsinsky Before August 5, 2024 to Discuss Your Rights - MRNS
NEW YORK, NY / ACCESSWIRE / July 1, 2024 / If you suffered a loss on your Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) investment and want to learn about a potential recovery under the federal securiti...